Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.

Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.

Our client is the owner of world class contract manufacturers that specialize in MedTech machining, surgical instruments and other associated devices, machinery and services. Capabilities include precision micro machining, engineering and prototyping, med device PCB fabrication and assembly. Of particular interest are filtration, micro maching and cabling & connection technologies.

Welcome to Tim Kelleher, Former President, Teleflex OEM who has joined Middle Branch Partner’s Board of Advisors. Under his leadership as President, the Teleflex Medical OEM business unit created three world class EPIC Medtec® Centers, completed a number of key acquisitions, and expanded its manufacturing and development footprint in seven locations, leading to a significant increase in the growth and profitability of the business.

Carolyn LaWell of Orthoworld offers this advice regarding medical device commercialization in emerging markets: consider new geographies early in your worldwide expansion based on ease of regulatory and reimbursement processes.

Content republished with permission from ORTHOWORLD® Inc.

Early earnings previews from companies reinforce Orthoworld’s belief that the orthopedic market will decline around -10% in 2020. Below they preview some positives from the fourth quarter and the most recent COVID and U.S. jobs data, as well as some early thoughts for 2021.

Content republished with permission from ORTHOWORLD® Inc.

Our client is a world class contract manufacturer that specializes in implants, surgical instruments and other associated devices and services. They are able to serve their customers world-wide due to their unique global footprint.

Our partners Larry Barr, Göran Brorsson, and Chuck Weikel sat down to discuss the state of MedTech M&A and expectations for the new year.

There is no question that there is larger distance between European markets today and anytime in recent memory. This had begun before Covid-19 with protectionist trade policies and then continued up to today, as travel restrictions and limitations on visits and shut down much M/A activity, both in Europe and North America. To understand this in greater detail, Chuck Weikel discussed with Göran Brorsson, our European Partner at Middle Branch Partners, about what he is experiencing in the European market.